1. Home
  2. KPRX vs TLIH Comparison

KPRX vs TLIH Comparison

Compare KPRX & TLIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

HOLD

Current Price

$2.54

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$5.76

Market Cap

12.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPRX
TLIH
Founded
1998
1998
Country
United States
Singapore
Employees
13
70
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
12.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KPRX
TLIH
Price
$2.54
$5.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
20.9K
5.9K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.34
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$0.22
52 Week High
$2.99
$5.96

Technical Indicators

Market Signals
Indicator
KPRX
TLIH
Relative Strength Index (RSI) N/A 66.56
Support Level N/A $0.30
Resistance Level N/A $5.93
Average True Range (ATR) 0.00 0.27
MACD 0.00 -0.06
Stochastic Oscillator 0.00 85.65

Price Performance

Historical Comparison
KPRX
TLIH

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

Share on Social Networks: